Orlando, Fla—Many individuals with opioid
addictions who might otherwise go untreated are seeking office-based buprenorphine
treatment and many are having positive outcomes, according to emerging data
on the 3-year-old treatment program. But challenges remain for patients seeking
care and the physicians who treat them.
Office-based buprenorphine treatment represents a new paradigm for treating
opioid addiction. While methadone treatment through clinics has proven effective
for many with opioid addictions, the stigma associated with the clinics, constraints
on their locations, and the logistics of getting to them for daily treatment
have been obstacles for some individuals, explained Arlene Stanton, PhD, social
science analyst at the Center for Substance Abuse Treatment at the Substance
Abuse and Mental Health Services Administration (SAMHSA) in Washington, DC.
Officials hoped that making buprenorphine available through qualified primary
care physicians and addiction specialists would attract a new group of patients
Kuehn BM. Office-Based Treatment for Opioid Addiction Achieving Goals. JAMA. 2005;294(7):784-786. doi:10.1001/jama.294.7.784